Patients Struggle With Life Quality But Hold to Treatments: US Survey
More than half of the people with amyotrophic lateral sclerosis (ALS) responding to a survey were dissatisfied with their…
Articles by Marta Figueiredo, PhD
WVE-004 Trial in Patients With C9orf72 Mutations Gains Funding
Wave Life Sciences has gained additional financial support for an ongoing “basket” Phase 1b/2a clinical trial evaluating its experimental…
Grant Supports Screening Platform for Potential Vaccine
Amarna Therapeutics and Redoxis have received an €800,000 (about $900,000) grant from Eureka Eurostars to advance their joint…
InFlectis OK’d to Start Phase 2 Trial of IFB-088 for Bulbar-onset ALS
The French health authority ANSM has approved InFlectis BioScience’s request to launch a Phase 2 clinical trial testing its lead…
AcuraStem’s AS-202 for ALS Shows Promise in Preclinical Studies
AcuraStem’s experimental therapy AS-202 significantly reduced neurodegeneration and improved motor function and survival in a mouse model of aggressive…
Pridopidine Arm of HEALEY ALS Platform Trial Fully Enrolled
Prilenia Therapeutics announced the completion of patient enrollment in the pridopidine arm of the HEALEY ALS platform trial,…
Amylyx Files for European Approval of AMX0035 in Treating ALS
Amylyx Pharmaceuticals has filed an application with the European Medicines Agency seeking the approval of its lead candidate…
ALS Linked to Neurons’ Death in Retina, a Potential Biomarker
Amyotrophic lateral sclerosis (ALS) leads to neuron damage in an eye layer called the retina through the activation of…
NurOwn Benefits Patients With Less Severe ALS, Analyses Show
A significantly greater proportion of amyotrophic lateral sclerosis (ALS) patients with less severe disease showed slower ALS progression with…
Enrollment Continuing in REFINE-ALS Biomarker Study for Radicava
Thanks to the implementation of proactive safety measures for the COVID-19 pandemic, Mitsubishi Tanabe Pharma America (MTPA) has enrolled…